Lates News

Every Business AI Express, Pacific Securities released a research report on November 1, giving Buy rating to Beida Medical (688073.SH). The main reasons for the rating include: 1) Revenue growth in line with expectations, profit growth exceeds expectations; 2) Profitability continues to improve, sales and R&D expense ratio continuously optimized; 3) The company continues to invest in research and development, enriching the number of molecular bricks. (Daily Economic News)